GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » EBITDA Margin %

Vilacto Bio (Vilacto Bio) EBITDA Margin % : -6,640.00% (As of Jun. 2019)


View and export this data going back to 2013. Start your Free Trial

What is Vilacto Bio EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Vilacto Bio's EBITDA for the three months ended in Jun. 2019 was $-0.33 Mil. Vilacto Bio's Revenue for the three months ended in Jun. 2019 was $0.01 Mil. Therefore, Vilacto Bio's EBITDA margin for the quarter that ended in Jun. 2019 was -6,640.00%.


Vilacto Bio EBITDA Margin % Historical Data

The historical data trend for Vilacto Bio's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilacto Bio EBITDA Margin % Chart

Vilacto Bio Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
EBITDA Margin %
Get a 7-Day Free Trial - - - -84,900.00 -114,240.00

Vilacto Bio Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -206,100.00 -270,300.00 -54,950.00 -6,640.00

Competitive Comparison of Vilacto Bio's EBITDA Margin %

For the Biotechnology subindustry, Vilacto Bio's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vilacto Bio's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vilacto Bio's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Vilacto Bio's EBITDA Margin % falls into.



Vilacto Bio EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Vilacto Bio's EBITDA Margin % for the fiscal year that ended in Mar. 2019 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2019 )/Revenue (A: Mar. 2019 )
=-5.712/0.005
=-114,240.00 %

Vilacto Bio's EBITDA Margin % for the quarter that ended in Jun. 2019 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2019 )/Revenue (Q: Jun. 2019 )
=-0.332/0.005
=-6,640.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vilacto Bio  (GREY:VIBI) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Vilacto Bio EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Vilacto Bio's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vilacto Bio (Vilacto Bio) Business Description

Traded in Other Exchanges
N/A
Address
Fabriksvej 48, Suite 2607, The Seagram Building, Naestved, DNK, 4700
Vilacto Bio Inc is a biotech company. It operates a fully patented Lactoactive molecule for treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. The company is also intended to develop Lactoactive molecule for increasing the quality of its retail and medical skin cream product as well as developing products for medical applications. Its product portfolio includes lotions, skin care creams and gels, lip balms, foot creams and oils, and others.